Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Calcium-sensing receptor modulators described in a recent CNRS patent

March 28, 2002

Aventis and Eisai to copromote Actonel in Japan

March 28, 2002

Takeda researchers identify new GnRH antagonists and their use

March 27, 2002

Roche licenses SEP from Gryphon Sciences

March 27, 2002

Potent and selective antagonist of human Y5 receptor identified at Fujisawa

March 27, 2002

No dose adjustment required for LY-333531 in renally impaired patients

March 27, 2002

Ivax completes pilot phase II study of E2CDS in postmenopausal women

March 26, 2002

Antagonists of human 11CBy receptor claimed for diabetes, depression, etc.

March 25, 2002

Label change for Xenical cleared by CPMP

March 25, 2002

Hemolink deemed not approvable by Canadian authorities

March 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...